VERU INC. Fixtures and Equipment, Gross
VERU INC. (VERU) had Fixtures and Equipment, Gross of $4.02 million as of 2018-09-30, per its 10-K filed 2018-12-13.
Discontinued › Balance Sheet › Assets › Real Estate Investment Property, at Cost
us-gaap:FixturesAndEquipmentGross · last filed 2018-12-13
- 2018-09-30: Fixtures and Equipment, Gross $4.02M.
- 2018-06-30: Fixtures and Equipment, Gross $4.07M.
- 2018-03-31: Fixtures and Equipment, Gross $4.07M.
- 2017-12-31: Fixtures and Equipment, Gross $4.07M.
| Period end | Fixtures and Equipment, Gross | Fixtures and Equipment, Gross as first filed |
|---|---|---|
| 2018-09-30 | $4.02M 10-K · filed 2018-12-13 | |
| 2018-06-30 | $4.07M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $4.07M 10-Q · filed 2018-05-11 | |
| 2017-12-31 | $4.07M 10-Q · filed 2018-02-14 | |
| 2017-09-30 | $4.07M 10-K · filed 2018-12-13 | |
| 2017-06-30 | $4.17M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $4.19M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $4.17M 10-Q · filed 2017-02-09 | |
| 2016-09-30 | $4.63M 10-K · filed 2018-01-02 | |
| 2016-06-30 | $4.62M 10-Q · filed 2016-07-28 | |
| 2016-03-31 | $4.62M 10-Q · filed 2016-04-28 | |
| 2015-12-31 | $4.63M 10-Q · filed 2016-02-02 | |
| 2015-09-30 | $4.68M 10-K · filed 2016-12-12 | |
| 2014-09-30 | $4.59M 10-K · filed 2015-12-02 | |
| 2013-03-31 | $4.76M 10-Q · filed 2013-05-02 | |
| 2012-12-31 | $4.51M 10-Q · filed 2013-01-30 | |
| 2012-09-30 | $4.29M 10-Q · filed 2013-05-02 | $3.97M 10-K · filed 2012-12-04 |
| 2012-06-30 | $4.02M 10-Q · filed 2012-07-31 | |
| 2012-03-31 | $4.04M 10-Q · filed 2012-05-01 | |
| 2011-12-31 | $3.86M 10-Q · filed 2012-01-31 | |
| 2011-09-30 | $3.47M 10-K · filed 2012-12-04 | $3.77M 10-K · filed 2011-12-02 |
| 2011-06-30 | $3.76M 10-Q · filed 2011-08-05 | |
| 2010-09-30 | $3.72M 10-K · filed 2011-12-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |